← 返回靶基因列表
🔬 剪接因子 PABPN1 靶基因疾病富集分析
| 疾病名称 | Overlap | P-value | 富集倍数 | 相关靶基因 |
|---|---|---|---|---|
| dengue disease | 18/212 | 0.002965 | 1.76x | FUS, PABPC1, YBX1, SF3B1, HNRNPA3, U2AF2, SF3B2, SRSF6, SNRNP200, SRRM2, PABPN1, HNRNPD, SRSF11, RBM5, SRSF5, HNRNPK, SRSF2, SRSF1 |
| genetic disorder | 12/113 | 0.003627 | 2.2x | NONO, TMEM63A, FUS, DDX6, U2AF2, MATR3, PABPN1, SRRM2, SNRNP200, SF3B2, HNRNPK, SRSF1 |
| Hodgkins lymphoma | 6/37 | 0.006217 | 3.35x | NONO, FUS, PABPC1, SF3B1, DDX6, SRSF2 |
| medulloblastoma | 3/10 | 0.009775 | 6.2x | DDX6, SF3B1, NONO |
| bronchoalveolar adenocarcinoma | 4/19 | 0.010441 | 4.35x | SF3B1, NONO, FUS, PABPC1 |
| melanoma | 7/55 | 0.012038 | 2.63x | NONO, FUS, PABPC1, YBX1, SF3B1, DDX6, SRSF2 |
| monoclonal B-cell lymphocytosis | 2/4 | 0.012792 | 10.34x | DAZAP1, SF3B1 |
| teratoma | 2/4 | 0.012792 | 10.34x | DDX6, PABPC1 |
| non-small cell lung carcinoma | 7/58 | 0.016063 | 2.5x | NONO, FUS, YBX1, SF3B1, DDX6, RBM5, SRSF2 |
| leiomyosarcoma | 3/12 | 0.016770 | 5.17x | DDX6, SRSF2, FUS |
| myelodysplastic syndrome | 4/22 | 0.017776 | 3.76x | DDX6, SF3B1, SRSF2, FUS |
| B-cell acute lymphoblastic leukemia | 6/46 | 0.018288 | 2.7x | NONO, FUS, PABPC1, SF3B1, DDX6, SRSF2 |
| Endometrial Serous Adenocarcinoma | 2/5 | 0.020679 | 8.27x | DDX6, FUS |
| orbit embryonal rhabdomyosarcoma | 2/5 | 0.020679 | 8.27x | DDX6, SRSF2 |
| pancreatic neoplasm | 2/5 | 0.020679 | 8.27x | DDX6, SF3B1 |
| anaplastic oligodendroglioma | 4/23 | 0.020793 | 3.6x | DDX6, SF3B1, SRSF2, PABPC1 |
| papillary thyroid carcinoma | 6/48 | 0.022339 | 2.58x | NONO, FUS, PABPC1, SF3B1, DDX6, SRSF2 |
| small cell lung carcinoma | 6/48 | 0.022339 | 2.58x | NONO, FUS, PABPC1, SF3B1, DDX6, SRSF2 |
| multiple myeloma | 6/49 | 0.024579 | 2.53x | NONO, FUS, PABPC1, SF3B1, DDX6, SRSF2 |
| acute myeloid leukemia | 7/63 | 0.024813 | 2.3x | NONO, FUS, PABPC1, SF3B1, DDX6, U2AF2, SRSF2 |
| lung adenocarcinoma | 7/63 | 0.024813 | 2.3x | NONO, FUS, PABPC1, YBX1, SF3B1, DDX6, SRSF2 |
| central nervous system primitive neuroectodermal neoplasm | 6/50 | 0.026969 | 2.48x | NONO, FUS, PABPC1, SF3B1, DDX6, SRSF2 |
| Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation | 6/51 | 0.029513 | 2.43x | NONO, FUS, PABPC1, SF3B1, DDX6, SRSF2 |
| Generalized hypotonia | 2/6 | 0.030088 | 6.89x | DDX6, HNRNPK |
| nasopharyngeal carcinoma | 2/6 | 0.030088 | 6.89x | HNRNPK, YBX1 |
| Gallbladder Adenocarcinoma | 5/38 | 0.030487 | 2.72x | NONO, FUS, PABPC1, DDX6, SF3B1 |
| hepatocellular carcinoma | 10/113 | 0.031789 | 1.83x | NONO, FUS, PABPC1, YBX1, SF3B1, DDX6, HNRNPD, HNRNPK, SRSF2, SRSF1 |
| ovarian serous adenocarcinoma | 6/52 | 0.032213 | 2.39x | NONO, FUS, PABPC1, SF3B1, DDX6, SRSF2 |
| brain glioblastoma | 6/53 | 0.035073 | 2.34x | NONO, FUS, PABPC1, SF3B1, DDX6, SRSF2 |
| Gallbladder Small Cell Neuroendocrine Carcinoma | 3/16 | 0.037400 | 3.88x | DDX6, SF3B1, FUS |
💡 说明:
• Overlap: 靶基因中与该疾病相关的基因数 / 数据库中该疾病总关联基因数
• P-value: 超几何检验显著性,越小代表富集越显著
• 富集倍数: 实际关联数 / 期望关联数,>1 表示富集
• Overlap: 靶基因中与该疾病相关的基因数 / 数据库中该疾病总关联基因数
• P-value: 超几何检验显著性,越小代表富集越显著
• 富集倍数: 实际关联数 / 期望关联数,>1 表示富集